PubMed

Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease.

Wei L, MacDonald TM, Walker BR.

Ann Intern Med. 2004 Nov 16;141(10):764-70.PMID: 15545676 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG, Walker BR.

Heart. 2004 Aug;90(8):859-65.PMID: 15253953 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study.

Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE.

Arthritis Rheum. 2007 Mar;56(3):820-30.PMID: 17330254 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis.

Panoulas VF, Douglas KM, Stavropoulos-Kalinoglou A, Metsios GS, Nightingale P, Kita MD, Elisaf MS, Kitas GD.

Rheumatology (Oxford). 2008 Jan;47(1):72-5.PMID: 18077493 [PubMed - indexed for MEDLINE]Related articles

Administrative claims analysis of the relationship between warfarin use and risk of hemorrhage including drug-drug and drug-disease interactions.

Zhang K, Young C, Berger J.

J Manag Care Pharm. 2006 Oct;12(8):640-8.PMID: 17269842 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Glucocorticoid medications and the risk for cardiovascular disease.

[No authors listed]

Ann Intern Med. 2004 Nov 16;141(10):I58. No abstract available. PMID: 15545672 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica.

Maradit Kremers H, Reinalda MS, Crowson CS, Davis JM 3rd, Hunder GG, Gabriel SE.

Arthritis Rheum. 2007 Mar 15;57(2):279-86.PMID: 17330277 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.

Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, Schneeweiss S.

Arthritis Rheum. 2006 Dec;54(12):3790-8.PMID: 17136752 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.

Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S.

Arthritis Rheum. 2006 May;54(5):1378-89.PMID: 16645966 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study.

Huang WF, Hsiao FY, Tsai YW, Wen YW, Shih YT.

Drug Saf. 2006;29(3):261-72.PMID: 16524325 [PubMed - indexed for MEDLINE]Related articles

Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study.

Sihvonen S, Korpela M, Mustonen J, Huhtala H, Karstila K, Pasternack A.

J Rheumatol. 2006 Sep;33(9):1740-6. Epub 2006 Aug 1.PMID: 16881099 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular follow-up at school age after perinatal glucocorticoid exposure in prematurely born children: perinatal glucocorticoid therapy and cardiovascular follow-up.

de Vries WB, Karemaker R, Mooy NF, Strengers JL, Kemperman H, Baerts W, Veen S, Visser GH, Heijnen CJ, van Bel F.

Arch Pediatr Adolesc Med. 2008 Aug;162(8):738-44.PMID: 18678806 [PubMed - indexed for MEDLINE]Related articlesFree article

The association between coeliac disease and cardiovascular disease.

Wei L, Spiers E, Reynolds N, Walsh S, Fahey T, MacDonald TM.

Aliment Pharmacol Ther. 2008 Mar 15;27(6):514-9. Epub 2007 Dec 21.PMID: 18162081 [PubMed - indexed for MEDLINE]Related articlesFree article

Triptan use and risk of cardiovascular events: a nested-case-control study from the French health system database.

Lugardon S, Roussel H, Sciortino V, Montastruc JL, Lapeyre-Mestre M.

Eur J Clin Pharmacol. 2007 Aug;63(8):801-7. Epub 2007 Jun 19.PMID: 17576547 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.

Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B.

JAMA. 2005 Apr 13;293(14):1737-45.PMID: 15827312 [PubMed - indexed for MEDLINE]Related articlesFree article

Fracture risk with intermittent high-dose oral glucocorticoid therapy.

De Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, Van Staa TP.

Arthritis Rheum. 2007 Jan;56(1):208-14.PMID: 17195223 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids.

Schols AM, Wesseling G, Kester AD, de Vries G, Mostert R, Slangen J, Wouters EF.

Eur Respir J. 2001 Mar;17(3):337-42.PMID: 11405508 [PubMed - indexed for MEDLINE]Related articlesFree article

Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P.

BMJ. 2008 Jun 28;336(7659):1475-82. Epub 2008 Jun 23.PMID: 18573856 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk of cardiovascular events in patients at optimal values for combined lipid parameters.

Stanek EJ, Sarawate C, Willey VJ, Charland SL, Cziraky MJ.

Curr Med Res Opin. 2007 Mar;23(3):553-63.PMID: 17357251 [PubMed - indexed for MEDLINE]Related articles

Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.

Layton D, Souverein PC, Heerdink ER, Shakir SA, Egberts AC.

Drug Saf. 2008;31(2):143-58.PMID: 18217790 [PubMed - indexed for MEDLINE]Related articles